EUVIMEDEUVIMED entdecken
Crossref

The Function of Angiotensin-Converting Enzyme Inhibitors in Chronic Kidney Disease: Pathophysiological Mechanisms and Implications for Practice

Said Salim Said, Burhani Simai, Sabra Salim Rashid, Ahmad Makame Mwadini, Ussi Hamza Ussi

Clinical Pharmacy Connect · 2026

DOI: 10.69709/cpc.2026.144454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacy Connect, 2026. Verfasst von Said Salim Said und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease is defined as a progressive deterioration in the functioning of the kidneys, and its progression is affected by many pathophysiological mechanisms. This disease still has a considerable effect on the health care system, especially concerning its relationship to cardiovascular disease. The progressive deterioration in the functioning of the kidneys is affected by complex mechanisms in the renin-angiotensin system and the inflammatory response, leading to permanent damage to the nephron. It has been found that angiotensinconverting enzyme inhibitors play an integral part in the management of chronic kidney disease. This is because, in addition to managing blood pressure, they produce renoprotective effects at the molecular level. In addition to giving a comprehensive overview, there is an indepth discussion concerning the mechanistic basis for the therapeutic effects of ACE inhibitors, especially concerning the effect on the renin-angiotensin-aldosterone system, the effect in reducing intraglomerular pressure, proteinuria, and anti-inflammatory effects. The long-term effects of ACE inhibitors are also discussed, especially concerning the results from clinical studies concerning delayed progression to end-stage renal failure, survival, and cardiovascular complications. Emphasis is placed on the pharmacodynamics of the initiation of therapy, especially concerning the effect on the glomerular filtration rate. The side effect profile concerning the long-term effects of ACE inhibitors is also discussed, especially concerning potassium, acute renal failure, and bradykinin. Other potential therapies concerning other agents, especially SGLT2, are also discussed. This comprehensive review concerning the role of ACE inhibitors in the management of chronic kidney disease places great emphasis on the need for personalized medicine.

Zitieren

APA

Said, S. S., Simai, B., Rashid, S. S., Mwadini, A. M., & Ussi, U. H. (2026). The Function of Angiotensin-Converting Enzyme Inhibitors in Chronic Kidney Disease: Pathophysiological Mechanisms and Implications for Practice. Clinical Pharmacy Connect. https://doi.org/10.69709/cpc.2026.144454

Vancouver

Said SS, Simai B, Rashid SS, Mwadini AM, Ussi UH. The Function of Angiotensin-Converting Enzyme Inhibitors in Chronic Kidney Disease: Pathophysiological Mechanisms and Implications for Practice. Clinical Pharmacy Connect. 2026. doi:10.69709/cpc.2026.144454

BibTeX
@article{Said2026,
  author = {Said, Said Salim and Simai, Burhani and Rashid, Sabra Salim and Mwadini, Ahmad Makame and Ussi, Ussi Hamza},
  title = {The Function of Angiotensin-Converting Enzyme Inhibitors in Chronic Kidney Disease: Pathophysiological Mechanisms and Implications for Practice},
  journal = {Clinical Pharmacy Connect},
  year = {2026},
  doi = {10.69709/cpc.2026.144454}
}
Kostenlos starten →